Spatial distribution of cerebral white matter lesions predicts progression to mild cognitive impairment and dementia

Marion Mortamais1, Christelle Reynes, Adam M Brickman

  • 1Inserm, U1061, La Colombière Hospital, Montpellier, France.

Plos One
|March 5, 2013
PubMed
Abstract

Insights

White matter lesions (WML) in the temporal lobe significantly increase the risk of mild cognitive impairment (MCI) or dementia. Identifying this WML pattern early can help detect at-risk individuals before symptoms appear.

Area of Science:

  • Neurology
  • Neuroimaging
  • Geriatrics

Background:

  • White matter lesions (WML) are linked to dementia risk.
  • The specific impact of WML location on cognitive decline is not well understood.

Purpose of the Study:

  • To investigate if a specific pattern of white matter lesion (WML) density and location predicts the risk of mild cognitive impairment (MCI) or dementia.
  • To analyze WML profiles in relation to cognitive decline over a 7-year period.

Main Methods:

  • Utilized data from 426 community-dwelling individuals aged 65+ (ESPRIT Project).
  • Employed a data mining approach (decision trees) to analyze regional and total WML volumes at baseline.
  • Applied Cox proportional hazard models to assess the association between WML patterns and MCI/dementia risk.

Main Results:

  • Total WML volume and the percentage of WML in the temporal region were the strongest predictors of MCI and dementia.
  • A high WML load, particularly with significant temporal lobe involvement, was significantly associated with increased risk.

Conclusions:

  • A WML pattern characterized by temporal lobe clustering, above a certain damage threshold, identifies individuals at higher risk for MCI or dementia.
  • This WML pattern can be detected before clinical symptoms, aiding in early identification of at-risk individuals.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...